The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Newly Diagnosed Glioblastoma
Official Title: Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma: A Randomized Double-blind Multicenter Prospective Phase II Study
Study ID: NCT04959500
Brief Summary: Addition of Anlotinib Hydrochloride to the Stupp Regimen Versus the Stupp Regimen Alone for Newly Diagnosed Glioblastoma.Take PFS as the main evaluation index, the purpose is to evaluate its effectiveness
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
Beijing TianTan Hospital,Capital Medical University, Beijing, Beijing Province, China
The Sixth Madical Center of PLA General Hospital, Beijing, Beijing, China
The General Hospital of the People's Liberation Army (PLAGH), Beijing, Beijing, China
Chongqing University Cancer Hospital, Chongqing, Chongqing Province, China
Fujian Provincial Cancer Hospital, Fuzhou, Fujian, China
Lanzhou University Second Hospital, Lanzhou, Gansu, China
The First Hospital of Lanzhou University, Lanzhou, Gansu, China
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Shenzhen People's Hospital, Shenzhen, Guangdong, China
The Fifth Affiliated Hospital Sun Yat-sen University, Zhuhai, Guangdong, China
The affiliated hospital of xuzhou medical university, Xuzhou, Jiangsu, China
The First Affiliated Hospital of NanChang University, Nanchang, Jiangxi, China
Jiangxi Cancer Hospital, Nanchang, Jiangxi, China
Gansu Provincial Hospital, Gansu, Lanzhou Province, China
Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, China
Fudan University shabghai cancer center, Shanghai, Shanghai, China
The Second Affiliated Hospital of PLA Air Force Medical University, Xian, Shanxi, China
West China Hospital,Sichuan University, Chengdu, Sichuan, China
Tianjin Medical University General Hospital, Tianjin, Tianjin, China
Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China
Name: Zhongping Chen, Doctor
Affiliation: Sun Yat-sen University
Role: PRINCIPAL_INVESTIGATOR